S&P 500   3,360.42 (+0.27%)
DOW   27,780.92 (+1.27%)
QQQ   269.94 (-0.56%)
AAPL   452.53 (+1.82%)
MSFT   207.33 (-2.42%)
FB   263.59 (-1.81%)
GOOGL   1,495.58 (-0.19%)
AMZN   3,148.91 (-0.59%)
NVDA   449.51 (+0.34%)
CGC   18.09 (+8.78%)
BABA   248.02 (-1.62%)
TSLA   1,422.76 (-2.06%)
MU   49.39 (+1.31%)
GE   6.65 (+3.91%)
AMD   82.66 (-2.58%)
T   30.16 (+0.47%)
F   7.07 (+3.06%)
ACB   10.26 (-0.10%)
GILD   68.43 (-1.33%)
NFLX   486.29 (-1.71%)
DIS   128.90 (-0.79%)
BAC   26.54 (+1.65%)
BA   178.28 (+4.86%)
S&P 500   3,360.42 (+0.27%)
DOW   27,780.92 (+1.27%)
QQQ   269.94 (-0.56%)
AAPL   452.53 (+1.82%)
MSFT   207.33 (-2.42%)
FB   263.59 (-1.81%)
GOOGL   1,495.58 (-0.19%)
AMZN   3,148.91 (-0.59%)
NVDA   449.51 (+0.34%)
CGC   18.09 (+8.78%)
BABA   248.02 (-1.62%)
TSLA   1,422.76 (-2.06%)
MU   49.39 (+1.31%)
GE   6.65 (+3.91%)
AMD   82.66 (-2.58%)
T   30.16 (+0.47%)
F   7.07 (+3.06%)
ACB   10.26 (-0.10%)
GILD   68.43 (-1.33%)
NFLX   486.29 (-1.71%)
DIS   128.90 (-0.79%)
BAC   26.54 (+1.65%)
BA   178.28 (+4.86%)
S&P 500   3,360.42 (+0.27%)
DOW   27,780.92 (+1.27%)
QQQ   269.94 (-0.56%)
AAPL   452.53 (+1.82%)
MSFT   207.33 (-2.42%)
FB   263.59 (-1.81%)
GOOGL   1,495.58 (-0.19%)
AMZN   3,148.91 (-0.59%)
NVDA   449.51 (+0.34%)
CGC   18.09 (+8.78%)
BABA   248.02 (-1.62%)
TSLA   1,422.76 (-2.06%)
MU   49.39 (+1.31%)
GE   6.65 (+3.91%)
AMD   82.66 (-2.58%)
T   30.16 (+0.47%)
F   7.07 (+3.06%)
ACB   10.26 (-0.10%)
GILD   68.43 (-1.33%)
NFLX   486.29 (-1.71%)
DIS   128.90 (-0.79%)
BAC   26.54 (+1.65%)
BA   178.28 (+4.86%)
S&P 500   3,360.42 (+0.27%)
DOW   27,780.92 (+1.27%)
QQQ   269.94 (-0.56%)
AAPL   452.53 (+1.82%)
MSFT   207.33 (-2.42%)
FB   263.59 (-1.81%)
GOOGL   1,495.58 (-0.19%)
AMZN   3,148.91 (-0.59%)
NVDA   449.51 (+0.34%)
CGC   18.09 (+8.78%)
BABA   248.02 (-1.62%)
TSLA   1,422.76 (-2.06%)
MU   49.39 (+1.31%)
GE   6.65 (+3.91%)
AMD   82.66 (-2.58%)
T   30.16 (+0.47%)
F   7.07 (+3.06%)
ACB   10.26 (-0.10%)
GILD   68.43 (-1.33%)
NFLX   486.29 (-1.71%)
DIS   128.90 (-0.79%)
BAC   26.54 (+1.65%)
BA   178.28 (+4.86%)
Log in

NYSEAMERICAN:MLSSMilestone Scientific Stock Price, Forecast & News

$1.91
+0.03 (+1.60 %)
(As of 08/10/2020 02:58 PM ET)
Add
Compare
Today's Range
$1.83
Now: $1.91
$1.92
50-Day Range N/A
52-Week Range
$0.46
Now: $1.91
$3.05
Volume4,185 shs
Average Volume482,043 shs
Market Capitalization$105.95 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Milestone Scientific, Inc. develops computer-controlled anesthetic delivery devices for the medical and dental markets in the United States and internationally. The company operates through dental and medical segments. Its products include CompuDent System used to control the flow rate of the anesthesia during the injection that allows virtually painless injections for various dental procedures, including routine fillings, implants, root canals, and crowns; and CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances. CompuFlo also includes a disposable injection handpiece for the tactile control during the injection; CompuFlo Epidural, a computer controlled anesthesia system for use in various medical applications; CompuFlo Intra-Articular, a computer controlled injection system for administering corticosteroids and other medicaments; CompuMed for use in various applications, such as plastic, hair restoration, podiatry, colorectal, dermatology, orthopedics, and various other surgeries. Its products also comprising Cosmetic Botulinum Injection device for the pain free injection of botulinum toxin; Veterinary Nerve Block Anesthesia device; the Wand Single Tooth Anesthesia System; and other devices. Milestone Scientific, Inc. was founded in 1989 and is headquartered in Livingston, New Jersey.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.20 out of 5 stars


Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Medical Instruments & Supplies
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:MLSS
CUSIPN/A
Phone+1-973-5352717

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees16
Market Cap$105.95 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable
$1.91
+0.03 (+1.60 %)
(As of 08/10/2020 02:58 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive MLSS News and Ratings via Email

Sign-up to receive the latest news and ratings for MLSS and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Milestone Scientific (NYSEAMERICAN:MLSS) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Milestone Scientific?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Milestone Scientific in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Milestone Scientific
.

When is Milestone Scientific's next earnings date?

Milestone Scientific is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020.
View our earnings forecast for Milestone Scientific
.

How were Milestone Scientific's earnings last quarter?

Milestone Scientific Inc. (NYSEAMERICAN:MLSS) posted its earnings results on Friday, May, 15th. The medical instruments supplier reported ($0.03) EPS for the quarter. The medical instruments supplier earned $1.81 million during the quarter.
View Milestone Scientific's earnings history
.

What price target have analysts set for MLSS?

1 Wall Street analysts have issued twelve-month price objectives for Milestone Scientific's shares. Their forecasts range from $4.00 to $4.00. On average, they expect Milestone Scientific's share price to reach $4.00 in the next twelve months. This suggests a possible upside of 109.4% from the stock's current price.
View analysts' price targets for Milestone Scientific
.

Has Milestone Scientific been receiving favorable news coverage?

News articles about MLSS stock have been trending very positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies positive and negative media coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Milestone Scientific earned a daily sentiment score of 3.2 on InfoTrie's scale. They also gave news stories about the medical instruments supplier a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an effect on the company's share price in the immediate future.
View the latest news about Milestone Scientific
.

Who are some of Milestone Scientific's key competitors?

What other stocks do shareholders of Milestone Scientific own?

Who are Milestone Scientific's key executives?

Milestone Scientific's management team includes the following people:
  • Mr. Leonard A. Osser, Founder, Interim CEO & Director (Age 72)
  • Mr. Joseph D'Agostino CPA, CPA, CFO & COO (Age 67)
  • Ms. Sharon Smith, Exec. VP of Global Sales & Marketing
  • Mr. Gian Domenico Trombetta, Pres & CEO of Wand Dental Inc. and Director (Age 58)
  • Mr. James McAvinn, Sr. VP of Sales & Marketing

What is Milestone Scientific's stock symbol?

Milestone Scientific trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "MLSS."

Who are Milestone Scientific's major shareholders?

Milestone Scientific's stock is owned by a number of retail and institutional investors. Top institutional investors include New York State Common Retirement Fund (0.07%) and QCI Asset Management Inc. NY (0.05%). Company insiders that own Milestone Scientific stock include Edward J Zelnick and Leonard Osser.
View institutional ownership trends for Milestone Scientific
.

Which institutional investors are selling Milestone Scientific stock?

MLSS stock was sold by a variety of institutional investors in the last quarter, including QCI Asset Management Inc. NY.
View insider buying and selling activity for Milestone Scientific
.

Which institutional investors are buying Milestone Scientific stock?

MLSS stock was purchased by a variety of institutional investors in the last quarter, including New York State Common Retirement Fund. Company insiders that have bought Milestone Scientific stock in the last two years include Edward J Zelnick, and Leonard Osser.
View insider buying and selling activity for Milestone Scientific
.

How do I buy shares of Milestone Scientific?

Shares of MLSS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Milestone Scientific's stock price today?

One share of MLSS stock can currently be purchased for approximately $1.91.

How big of a company is Milestone Scientific?

Milestone Scientific has a market capitalization of $105.95 million. Milestone Scientific employs 16 workers across the globe.

What is Milestone Scientific's official website?

The official website for Milestone Scientific is www.milesci.com.

How can I contact Milestone Scientific?

Milestone Scientific's mailing address is 220 S Orange Ave, LIVINGSTON, NJ 07039-5804, United States. The medical instruments supplier can be reached via phone at +1-973-5352717.

This page was last updated on 8/10/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.